ArriVent BioPharma Inc. C... (AVBP)
NASDAQ: AVBP
· Real-Time Price · USD
19.54
0.92 (4.94%)
At close: Aug 15, 2025, 3:59 PM
19.58
0.20%
After-hours: Aug 15, 2025, 05:41 PM EDT
ArriVent BioPharma Common Stock Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -136.98M | -127.46M | -80.49M | -81.05M | -74.89M | -74.58M | -69.33M | -58.58M | -55.95M | -41.73M | -36.91M | -26.46M | -14.7M | -7.35M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 7.4M | 4.86M | 3.21M | 2.58M | 1.93M | 1.35M | 895K | 689K | 585K | 491K | 424K | 311K | 198K | 99K |
Other Working Capital | 2.71M | 2.81M | 7.82M | 9.09M | 7.54M | 14.25M | 11.22M | -26K | -1.46M | -12.49M | -9.95M | -4.37M | -3.91M | -1.95M |
Other Non-Cash Items | n/a | -347K | -721K | -697K | 1.75M | -1.4M | -484K | -414K | -666K | 3.13M | 2.88M | 2.78M | 586K | 293K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 2.95M | 3.36M | 7.41M | 9.85M | 5.24M | 15.63M | 12.6M | 1.08M | 1.87M | -12.85M | -9.93M | -4.37M | -3.91M | -1.95M |
Operating Cash Flow | -126.63M | -119.59M | -70.21M | -68.97M | -68.07M | -57.59M | -55.84M | -56.82M | -51.3M | -51.6M | -43.63M | -27.74M | -17.82M | -8.91M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -225.55M | -203.98M | -194.16M | n/a | n/a | -25M | -25M | -25M | -25M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 83.81M | 48.34M | 1.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 25M | 25M | 25M | 25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -141.73M | -155.64M | -192.47M | 25M | 25M | n/a | n/a | -25M | -25M | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 186M | 186.05M | 186.05M | -1.01M | -2.04M | -2.08M | -2.06M | -988K | 45K | 30.04M | 60.02M | 60M | 60M | 30M |
Financial Cash Flow | 82.46M | 7.71M | 186.58M | 185.47M | 183.91M | 183.52M | 42.86M | 153.64M | 154.67M | 184.69M | 169.72M | 60M | 60M | 30M |
Net Cash Flow | -185.9M | -267.53M | -76.1M | 141.5M | 140.84M | 125.93M | -12.98M | 71.82M | 78.37M | 191.46M | 163.37M | 69.54M | 79.46M | n/a |
Free Cash Flow | -126.63M | -119.59M | -70.21M | -68.97M | -68.07M | -57.59M | -55.84M | -56.82M | -51.3M | -51.6M | -43.63M | -27.74M | -17.82M | -8.91M |